Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Sonnet Biotherapeutics Holdings Inc. buy Chardan Capital

Sonnet Biotherapeutics Holdings Inc.
Start price
€0.18
15.02.24 / 50%
Target price
€27.86
15.02.25
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 15.02.25. The prediction end date can be changed by Chardan_Capital at any time.
Performance without dividends (%)
Name 1w 1m
Sonnet Biotherapeutics Holdings Inc. - -
iShares Core DAX® 2.594% -1.158%
iShares Nasdaq 100 3.553% -1.727%
iShares Nikkei 225® 0.687% -8.354%
iShares S&P 500 2.209% -0.942%

Comments by Chardan_Capital for this prediction

In the thread Sonnet Biotherapeutics Hldgs. Inc. diskutieren
Prediction Buy
Perf. (%) -
Target price 27.861
Change
Ends at 15.02.25

Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) had its price target lowered by analysts at Chardan Capital from $75.00 to $30.00. They now have a "buy" rating on the stock.
Ratings data for SONN provided by MarketBeat

Chardan Capital 
0
Report Share
15.02.24

Stopped prediction by Chardan_Capital for Sonnet Biotherapeutics Holdings Inc.

buy
Sonnet Biotherapeutics Holdings Inc.

Start price
Target price
Perf. (%)
€0.38
16.08.23
€11.00
16.08.24
-51.06%
20.11.23

Chardan Capital 
16.08.23 50%